Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis

Liver International

Volumn 34, Issue 1, 2014, Pages 16-25

  Reverter, Enric ^a,b   Blasi, Annabel ^a   Abraldes, Juan G ^a,b   Martínez Palli, Graciela ^a   Seijo, Susana ^a,b   Turon, Fanny ^a,b   Berzigotti, Annalisa ^a,b   Balust, Jaume ^a   Bosch, Jaume ^a,b   García Pagán, Juan C ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Anaesthesia; Portal hypertension; Propofol; Remifentanil; TIPS

Indexed keywords

PROPOFOL; PROPRANOLOL; REMIFENTANIL;

ABDOMINAL PRESSURE; ACCURACY; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BREATHING; BREATHING PATTERN; CLINICAL ARTICLE; DEEP SEDATION; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEART OUTPUT; HUMAN; LIVER CIRRHOSIS; LIVER VEIN; LUNG RESISTANCE; MALE; OSCILLATION; PORTAL VEIN BLOOD PRESSURE; PROGNOSIS; RAMSAY SEDATION SCALE; SEDATION; VENOUS PRESSURE;

ANAESTHESIA; PORTAL HYPERTENSION; PROPOFOL; REMIFENTANIL; TIPS;

ADULT; AGED; ANESTHETICS, INTRAVENOUS; BLOOD PRESSURE DETERMINATION; DEEP SEDATION; FEMALE; HEPATIC VEINS; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PIPERIDINES; PORTAL PRESSURE; PORTAL VEIN; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PREDICTIVE VALUE OF TESTS; PROPOFOL; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RESPIRATORY MECHANICS; TIME FACTORS;

EID: 84890031000     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12229     Document Type: Article

References (45)

1. Feu F, Garcia-Pagan JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995; 346: 1056-9.
2. Villanueva C, Aracil C, Colomo A, et al. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology 2009; 137: 119-28.
3. La Mura V, Abraldes JG, Raffa S, et al. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension. J Hepatol 2009; 51: 279-87.
4. Abraldes JG, Tarantino I, Turnes J, et al. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003; 37: 902-8.
5. D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006; 131: 1611-24.
6. Bosch J, Abraldes JG, Berzigotti A, Garcia-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009; 6: 576-82.
7. Bosch J, Garcia-Pagan JC, Berzigotti A, Abraldes JG. Measurement of portal pressure and its role in the management of chronic liver disease. Semin Liver Dis 2006; 26: 348-62.
8. Steinlauf AF, Garcia-Tsao G, Zakko MF, et al. Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements. Hepatology 1999; 29: 1070-3.
9. Miraglia R, Luca A, Maruzzelli L, et al. Measurement of hepatic vein pressure gradient in children with chronic liver diseases. J Hepatol 2010; 53: 624-9.
10. DeGasperi A, Corti A, Corso R, et al. Transjugular intrahepatic portosystemic shunt (TIPS): the anesthesiological point of view after 150 procedures managed under total intravenous anesthesia. J Clin Monit Comput 2009; 23: 341-6.
11. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41: 386-400.
12. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt (tips) in the management of portal hypertension: update 2009. Hepatology 2010; 51: 306.
13. Amoros A, Aparicio JR, Garmendia M, et al. Deep sedation with propofol does not precipitate hepatic encephalopathy during elective upper endoscopy. Gastrointest Endosc 2009; 70: 262-8.
14. Riphaus A, Lechowicz I, Frenz MB, Wehrmann T. Propofol sedation for upper gastrointestinal endoscopy in patients with liver cirrhosis as an alternative to midazolam to avoid acute deterioration of minimal encephalopathy: a randomized, controlled study. Scand J Gastroenterol 2009; 44: 1244-51.
15. Weston BR, Chadalawada V, Chalasani N, et al. Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients. Am J Gastroenterol 2003; 98: 2440-7.
16. Renwick J, Kerr C, McTaggart R, Yeung J. Cardiac electrophysiology and conduction pathway ablation. Can J Anaesth 1993; 40: 1053-64.
17. Lebovic S, Reich DL, Steinberg LG, Vela FP, Silvay G. Comparison of propofol versus ketamine for anesthesia in pediatric patients undergoing cardiac catheterization. Anesth Analg 1992; 74: 490-4.
18. Costela JL, Jimenez R, Calvo R, Suarez E, Carlos R. Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis. Acta Anaesthesiol Scand 1996; 40: 741-5.
19. Servin F, Desmonts JM, Haberer JP, et al. Pharmacokinetics and protein binding of propofol in patients with cirrhosis. Anesthesiology 1988; 69: 887-91.
20. Servin F, Cockshott ID, Farinotti R, et al. Pharmacokinetics of propofol infusions in patients with cirrhosis. Br J Anaesth 1990; 65: 177-83.
21. Tegeder I, Lotsch J, Geisslinger G. Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet 1999; 37: 17-40.
22. Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil II. Model application. Anesthesiology 1997; 86: 24-33.
23. Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil I. Model development. Anesthesiology 1997; 86: 10-23.
24. Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88: 1170-82.
25. Schnider TW, Minto CF, Shafer SL, et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90: 1502-16.
26. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974; 2: 656-9.
27. La Mura V, Abraldes JG, Berzigotti A, et al. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. Hepatology 2010; 51: 2108-16.
28. Bartko JJ. Measures of agreement: a single procedure. Stat Med 1994; 13: 737-45.
29. Szklo M, Nieto FJ. Epidemiology- Beyond the Basics. Gaithersburg (MD): Aspen Publishers, 2000.
30. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10.
31. Marino P.L, Sutin K.M. The ICU Book. Philadelphia: Lippincott Williams & Wilkins, ed. 2007; 181-92
32. Hernandez-Gea V, Aracil C, Colomo A, et al. Development of ascites in compensated cirrhosis with severe portal hypertension treated with beta-blockers. Am J Gastroenterol 2012; 107: 418-27.
33. Mandell MS, Durham J, Kumpe D, et al. The effects of desflurane and propofol on portosystemic pressure in patients with portal hypertension. Anesth Analg 2003; 97: 1573-7.
34. Casado M, Bosch J, Garcia-Pagan JC, et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998; 114: 1296-303.
35. Milne SE, Kenny GN, Schraag S. Propofol sparing effect of remifentanil using closed-loop anaesthesia. Br J Anaesth 2003; 90: 623-9.
36. Fulton B, Sorkin EM. Propofol. an overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995; 50: 636-57.
37. Grounds RM, Twigley AJ, Carli F, Whitwam JG, Morgan M. The haemodynamic effects of intravenous induction Comparison of the effects of thiopentone and propofol. Anaesthesia 1985; 40: 735-40.
38. James MK, Vuong A, Grizzle MK, Schuster SV, Shaffer JE. Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs. J Pharmacol Exp Ther 1992; 263: 84-91.
39. Sebel PS, Hoke JF, Westmoreland C, et al. Histamine concentrations and hemodynamic responses after remifentanil. Anesth Analg 1995; 80: 990-3.
40. Carmichael FJ, Crawford MW, Khayyam N, Saldivia V. Effect of propofol infusion on splanchnic hemodynamics and liver oxygen consumption in the rat a dose-response study. Anesthesiology 1993; 79: 1051-60.
41. Meierhenrich R, Gauss A, Muhling B, et al. The effect of propofol and desflurane anaesthesia on human hepatic blood flow: a pilot study. Anaesthesia 2010; 65: 1085-93.
42. Wouters PF, Van de Velde MA, Marcus MA, Deruyter HA, Van Aken AH. Hemodynamic changes during induction of anesthesia with eltanolone and propofol in dogs. Anesth Analg 1995; 81: 125-31.
43. Zhu T, Pang Q, McCluskey SA, Luo C. Effect of propofol on hepatic blood flow and oxygen balance in rabbits. Can J Anaesth 2008; 55: 364-70.
44. Vorobioff J, Bredfeldt JE, Groszmann RJ. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology 1984; 87: 1120-3.
45. Zipprich A, Loureiro-Silva MR, D'Silva I, Groszmann RJ. The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver. Am J Physiol Gastrointest Liver Physiol 2008; 295: G197-202.